Citation: E. Hanon et H. Klitgaard, Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia, SEIZURE-E J, 10(4), 2001, pp. 287-293
Authors:
Hanon, E
Goon, P
Taylor, GP
Hasegawa, H
Tanaka, Y
Weber, JN
Bangham, CRM
Citation: E. Hanon et al., High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells, BLOOD, 98(3), 2001, pp. 721-726
Authors:
Hanon, E
Stinchcombe, JC
Saito, M
Asquith, BE
Taylor, GP
Tanaka, Y
Weber, JN
Griffiths, GM
Bangham, CRM
Citation: E. Hanon et al., Fratricide among CD8(+) T lymphocytes naturally infected with human T celllymphotropic virus type I, IMMUNITY, 13(5), 2000, pp. 657-664
Authors:
Hanon, E
Asquith, RE
Taylor, GP
Tanaka, Y
Weber, JN
Bangham, CRM
Citation: E. Hanon et al., High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells, AIDS RES H, 16(16), 2000, pp. 1711-1715
Authors:
Lemaire, M
Hanon, E
Schynts, F
Meyer, G
Thiry, E
Citation: M. Lemaire et al., Specific passive immunity reduces the excretion of glycoprotein E-negativebovine herpesvirus type 1 vaccine strain in calves, VACCINE, 19(9-10), 2000, pp. 1013-1017
Authors:
Hanon, E
Hall, S
Taylor, GP
Saito, M
Davis, R
Tanaka, Y
Usuku, K
Osame, M
Weber, JN
Bangham, CRM
Citation: E. Hanon et al., Abundant Tax protein expression in CD4+T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes, BLOOD, 95(4), 2000, pp. 1386-1392